JONATHAN E LIM Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JONATHAN E LIM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN E LIM. JONATHAN E LIM is President and C. E. O. in HALOZYME THERAPEUTICS INC ($GYHT) and President and CEO in HALOZYME THERAPEUTICS INC ($GYHT) and President, CEO in HALOZYME THERAPEUTICS INC ($GYHT).
JONATHAN E LIM in HALOZYME THERAPEUTICS, INC.
Trading Symbol: GYHTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JONATHAN E LIM: President, CEO, President and C. E. O., President and CEO
Holdings: 700,000 shares
Latest Transaction: Oct 16 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JONATHAN E LIM in HALOZYME THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 16 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.45 | 26,690 | 12,000 | 2,227,313 | |
Oct 16 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.45 | 26,690 | 12,000 | 700,000 | 673.3 K to 700 K (+3.96 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 25,000 | 9,750 | 2,254,003 | |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.59 | 200 | 1,718 | 673,310 | 673.5 K to 673.3 K (-0.03 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.63 | 300 | 2,589 | 673,510 | 673.8 K to 673.5 K (-0.04 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.65 | 100 | 865 | 673,810 | 673.9 K to 673.8 K (-0.01 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.66 | 400 | 3,464 | 673,910 | 674.3 K to 673.9 K (-0.06 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.67 | 400 | 3,468 | 674,310 | 674.7 K to 674.3 K (-0.06 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.68 | 300 | 2,604 | 674,710 | 675 K to 674.7 K (-0.04 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.69 | 500 | 4,345 | 675,010 | 675.5 K to 675 K (-0.07 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.70 | 700 | 6,090 | 675,510 | 676.2 K to 675.5 K (-0.10 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.71 | 3,500 | 30,485 | 676,210 | 679.7 K to 676.2 K (-0.51 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.72 | 950 | 8,284 | 679,710 | 680.7 K to 679.7 K (-0.14 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.73 | 276 | 2,409 | 680,660 | 680.9 K to 680.7 K (-0.04 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.74 | 224 | 1,958 | 680,936 | 681.2 K to 680.9 K (-0.03 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.75 | 1,500 | 13,125 | 681,160 | 682.7 K to 681.2 K (-0.22 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.76 | 1,350 | 11,826 | 682,660 | 684 K to 682.7 K (-0.20 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.77 | 600 | 5,262 | 684,010 | 684.6 K to 684 K (-0.09 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.78 | 600 | 5,268 | 684,610 | 685.2 K to 684.6 K (-0.09 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.79 | 900 | 7,911 | 685,210 | 686.1 K to 685.2 K (-0.13 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.80 | 3,010 | 26,488 | 686,110 | 689.1 K to 686.1 K (-0.44 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.81 | 1,610 | 14,184 | 689,120 | 690.7 K to 689.1 K (-0.23 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.82 | 1,100 | 9,702 | 690,730 | 691.8 K to 690.7 K (-0.16 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.83 | 1,880 | 16,600 | 691,830 | 693.7 K to 691.8 K (-0.27 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.84 | 400 | 3,536 | 693,710 | 694.1 K to 693.7 K (-0.06 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.85 | 600 | 5,310 | 694,110 | 694.7 K to 694.1 K (-0.09 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.88 | 700 | 6,216 | 694,710 | 695.4 K to 694.7 K (-0.10 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.89 | 1,299 | 11,548 | 695,410 | 696.7 K to 695.4 K (-0.19 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.90 | 600 | 5,340 | 696,709 | 697.3 K to 696.7 K (-0.09 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.91 | 201 | 1,791 | 697,309 | 697.5 K to 697.3 K (-0.03 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.92 | 700 | 6,244 | 697,510 | 698.2 K to 697.5 K (-0.10 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.93 | 100 | 893 | 698,210 | 698.3 K to 698.2 K (-0.01 %) |
Oct 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 25,000 | 9,750 | 698,310 | 673.3 K to 698.3 K (+3.71 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.96 | 100 | 896 | 673,310 | 673.4 K to 673.3 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.95 | 400 | 3,580 | 673,410 | 673.8 K to 673.4 K (-0.06 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.94 | 584 | 5,221 | 673,810 | 674.4 K to 673.8 K (-0.09 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.93 | 516 | 4,608 | 674,394 | 674.9 K to 674.4 K (-0.08 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.92 | 200 | 1,784 | 674,910 | 675.1 K to 674.9 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.91 | 400 | 3,564 | 675,110 | 675.5 K to 675.1 K (-0.06 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.90 | 1,200 | 10,680 | 675,510 | 676.7 K to 675.5 K (-0.18 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.89 | 200 | 1,778 | 676,710 | 676.9 K to 676.7 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.88 | 100 | 888 | 676,910 | 677 K to 676.9 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.87 | 400 | 3,548 | 677,010 | 677.4 K to 677 K (-0.06 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.86 | 200 | 1,772 | 677,410 | 677.6 K to 677.4 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.85 | 800 | 7,080 | 677,610 | 678.4 K to 677.6 K (-0.12 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.84 | 1,000 | 8,840 | 678,410 | 679.4 K to 678.4 K (-0.15 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.83 | 1,000 | 8,830 | 679,410 | 680.4 K to 679.4 K (-0.15 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.82 | 200 | 1,764 | 680,410 | 680.6 K to 680.4 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.81 | 100 | 881 | 680,610 | 680.7 K to 680.6 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.80 | 200 | 1,760 | 680,710 | 680.9 K to 680.7 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.79 | 400 | 3,516 | 680,910 | 681.3 K to 680.9 K (-0.06 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.77 | 100 | 877 | 681,310 | 681.4 K to 681.3 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.76 | 100 | 876 | 681,410 | 681.5 K to 681.4 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.75 | 800 | 7,000 | 681,510 | 682.3 K to 681.5 K (-0.12 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.74 | 200 | 1,748 | 682,310 | 682.5 K to 682.3 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.73 | 100 | 873 | 682,510 | 682.6 K to 682.5 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.72 | 1,000 | 8,720 | 682,610 | 683.6 K to 682.6 K (-0.15 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.71 | 600 | 5,226 | 683,610 | 684.2 K to 683.6 K (-0.09 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.70 | 1,900 | 16,530 | 684,210 | 686.1 K to 684.2 K (-0.28 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 25,000 | 9,750 | 2,279,003 | |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.69 | 1,600 | 13,904 | 686,110 | 687.7 K to 686.1 K (-0.23 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.68 | 700 | 6,076 | 687,710 | 688.4 K to 687.7 K (-0.10 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.67 | 300 | 2,601 | 688,410 | 688.7 K to 688.4 K (-0.04 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.66 | 200 | 1,732 | 688,710 | 688.9 K to 688.7 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.64 | 300 | 2,592 | 688,910 | 689.2 K to 688.9 K (-0.04 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.63 | 400 | 3,452 | 689,210 | 689.6 K to 689.2 K (-0.06 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.62 | 1,400 | 12,068 | 689,610 | 691 K to 689.6 K (-0.20 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.61 | 100 | 861 | 691,010 | 691.1 K to 691 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.60 | 500 | 4,300 | 691,110 | 691.6 K to 691.1 K (-0.07 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.59 | 1,100 | 9,449 | 691,610 | 692.7 K to 691.6 K (-0.16 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.58 | 220 | 1,888 | 692,710 | 692.9 K to 692.7 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.57 | 220 | 1,885 | 692,930 | 693.2 K to 692.9 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.56 | 100 | 856 | 693,150 | 693.3 K to 693.2 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.55 | 200 | 1,710 | 693,250 | 693.5 K to 693.3 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.54 | 700 | 5,978 | 693,450 | 694.2 K to 693.5 K (-0.10 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.53 | 580 | 4,947 | 694,150 | 694.7 K to 694.2 K (-0.08 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.52 | 80 | 682 | 694,730 | 694.8 K to 694.7 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.51 | 100 | 851 | 694,810 | 694.9 K to 694.8 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.50 | 1,025 | 8,713 | 694,910 | 695.9 K to 694.9 K (-0.15 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.49 | 100 | 849 | 695,935 | 696 K to 695.9 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.48 | 600 | 5,088 | 696,035 | 696.6 K to 696 K (-0.09 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.47 | 260 | 2,202 | 696,635 | 696.9 K to 696.6 K (-0.04 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.46 | 40 | 338 | 696,895 | 696.9 K to 696.9 K (-0.01 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.42 | 200 | 1,684 | 696,935 | 697.1 K to 696.9 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.40 | 200 | 1,680 | 697,135 | 697.3 K to 697.1 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.35 | 400 | 3,340 | 697,335 | 697.7 K to 697.3 K (-0.06 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.34 | 200 | 1,668 | 697,735 | 697.9 K to 697.7 K (-0.03 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.31 | 105 | 873 | 697,935 | 698 K to 697.9 K (-0.02 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.30 | 270 | 2,241 | 698,040 | 698.3 K to 698 K (-0.04 %) |
Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 25,000 | 9,750 | 698,310 | 673.3 K to 698.3 K (+3.71 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 20,000 | 7,800 | 2,304,003 | |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.33 | 400 | 3,332 | 673,310 | 673.7 K to 673.3 K (-0.06 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.31 | 100 | 831 | 673,710 | 673.8 K to 673.7 K (-0.01 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.30 | 100 | 830 | 673,810 | 673.9 K to 673.8 K (-0.01 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.28 | 300 | 2,484 | 673,910 | 674.2 K to 673.9 K (-0.04 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.27 | 400 | 3,308 | 674,210 | 674.6 K to 674.2 K (-0.06 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.26 | 760 | 6,278 | 674,610 | 675.4 K to 674.6 K (-0.11 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.25 | 1,040 | 8,580 | 675,370 | 676.4 K to 675.4 K (-0.15 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.24 | 400 | 3,296 | 676,410 | 676.8 K to 676.4 K (-0.06 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.23 | 1,300 | 10,699 | 676,810 | 678.1 K to 676.8 K (-0.19 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.22 | 2,400 | 19,728 | 678,110 | 680.5 K to 678.1 K (-0.35 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.21 | 6,100 | 50,081 | 680,510 | 686.6 K to 680.5 K (-0.89 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.20 | 500 | 4,100 | 686,610 | 687.1 K to 686.6 K (-0.07 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.16 | 600 | 4,896 | 687,110 | 687.7 K to 687.1 K (-0.09 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.15 | 600 | 4,890 | 687,710 | 688.3 K to 687.7 K (-0.09 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.12 | 5,000 | 40,600 | 688,310 | 693.3 K to 688.3 K (-0.72 %) |
Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 20,000 | 7,800 | 693,310 | 673.3 K to 693.3 K (+2.97 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.61 | 400 | 3,844 | 673,310 | 673.7 K to 673.3 K (-0.06 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.60 | 1,099 | 10,550 | 673,710 | 674.8 K to 673.7 K (-0.16 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.59 | 3,700 | 35,483 | 674,809 | 678.5 K to 674.8 K (-0.55 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.59 | 400 | 3,834 | 678,509 | 678.9 K to 678.5 K (-0.06 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.58 | 800 | 7,664 | 678,909 | 679.7 K to 678.9 K (-0.12 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.57 | 1,000 | 9,570 | 679,709 | 680.7 K to 679.7 K (-0.15 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.57 | 200 | 1,913 | 680,709 | 680.9 K to 680.7 K (-0.03 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.56 | 600 | 5,736 | 680,909 | 681.5 K to 680.9 K (-0.09 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 25,000 | 9,750 | 2,324,003 | |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.55 | 1,200 | 11,460 | 681,509 | 682.7 K to 681.5 K (-0.18 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.54 | 700 | 6,678 | 682,709 | 683.4 K to 682.7 K (-0.10 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.54 | 200 | 1,907 | 683,409 | 683.6 K to 683.4 K (-0.03 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.53 | 500 | 4,765 | 683,609 | 684.1 K to 683.6 K (-0.07 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.52 | 1,374 | 13,080 | 684,109 | 685.5 K to 684.1 K (-0.20 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.52 | 100 | 952 | 685,483 | 685.6 K to 685.5 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.51 | 2,000 | 19,020 | 685,583 | 687.6 K to 685.6 K (-0.29 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.51 | 100 | 951 | 687,583 | 687.7 K to 687.6 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.50 | 1,100 | 10,450 | 687,683 | 688.8 K to 687.7 K (-0.16 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.49 | 100 | 949 | 688,783 | 688.9 K to 688.8 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.48 | 400 | 3,792 | 688,883 | 689.3 K to 688.9 K (-0.06 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.41 | 681 | 6,408 | 689,283 | 690 K to 689.3 K (-0.10 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.40 | 286 | 2,688 | 689,964 | 690.3 K to 690 K (-0.04 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.39 | 1,960 | 18,404 | 690,250 | 692.2 K to 690.3 K (-0.28 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.39 | 300 | 2,816 | 692,210 | 692.5 K to 692.2 K (-0.04 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.38 | 600 | 5,628 | 692,510 | 693.1 K to 692.5 K (-0.09 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.37 | 600 | 5,622 | 693,110 | 693.7 K to 693.1 K (-0.09 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.36 | 1,100 | 10,296 | 693,710 | 694.8 K to 693.7 K (-0.16 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.33 | 900 | 8,397 | 694,810 | 695.7 K to 694.8 K (-0.13 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.32 | 600 | 5,592 | 695,710 | 696.3 K to 695.7 K (-0.09 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.30 | 800 | 7,440 | 696,310 | 697.1 K to 696.3 K (-0.11 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.28 | 100 | 928 | 697,110 | 697.2 K to 697.1 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.27 | 200 | 1,854 | 697,210 | 697.4 K to 697.2 K (-0.03 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.26 | 300 | 2,778 | 697,410 | 697.7 K to 697.4 K (-0.04 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.24 | 100 | 924 | 697,710 | 697.8 K to 697.7 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.23 | 200 | 1,846 | 697,810 | 698 K to 697.8 K (-0.03 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.18 | 100 | 918 | 698,010 | 698.1 K to 698 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.17 | 100 | 917 | 698,110 | 698.2 K to 698.1 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.16 | 100 | 916 | 698,210 | 698.3 K to 698.2 K (-0.01 %) |
Jul 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 25,000 | 9,750 | 698,310 | 673.3 K to 698.3 K (+3.71 %) |
Jun 26 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 96,313 | 37,562 | 2,349,003 | |
Jun 26 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 96,313 | 37,562 | 673,310 | 577 K to 673.3 K (+16.69 %) |
Mar 24 2005 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President and C. E. ... | Option Exercise | M | 0.39 | 100,000 | 39,000 | 2,114,791 | |
Mar 24 2005 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President and C. E. ... | Buy | M | 0.39 | 100,000 | 39,000 | 589,497 | 489.5 K to 589.5 K (+20.43 %) |